Retrospective evaluation of the effects of sugammadex and neostigmine on the IgE and eosinophil cationic protein in morbid obese patients
- PMID: 33381696
- PMCID: PMC7754875
- DOI: 10.14744/nci.2020.21298
Retrospective evaluation of the effects of sugammadex and neostigmine on the IgE and eosinophil cationic protein in morbid obese patients
Abstract
Objective: This study was designed to show that allergic reactions with gamma cyclodextrin-related caused by sugammadex are not anaphylaxis but an anaphylactoid reaction.
Methods: In this retrospective study, 83 morbidly obese patients, who underwent elective laparoscopic sleeve gastrectomy operation, were included. Patient data were obtained from patient files and electronic health records system (SARUS). The patients were divided into two groups as sugammadex (Group S) and neostigmine (Group N). Patient data were recorded, including patient preoperative demographics (age, gender) and preoperative and postoperative (12 hours later) levels of total IgE and ECP (Eosinophil cationic protein) levels.
Results: There was not a significant change in the total IgE levels in Group S or Group N (p>0.05); however, the levels of ECP significantly decreased in both groups (p<0.001, p=0.01). In the patients in Group S, the preoperative levels of total IgE were significantly positively, and weakly correlated with the preoperative ECP (p=0.311, p=0.045) and postoperative ECP (p=0.310, p=0.046) levels.
Conclusion: Allergic reactions that arise from sugammadex related with gamma-cyclodextrin are non-IgE mediated anaphylactoid reactions. Anaphylactoid reaction was not observed after administration of 2 mg kg-1 sugammadex intravenously in patients with morbid obesity.
Keywords: Sugammadex; anaphylaxis; cyclodextrins; eosinophil cationic protein; immunoglobulin e; neostigmine.
Copyright: © 2020 by Istanbul Northern Anatolian Association of Public Hospitals.
Conflict of interest statement
Conflict of Interest: No conflict of interest was declared by the authors.
Figures
Similar articles
-
The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact.Clinicoecon Outcomes Res. 2016 Jun 29;8:317-22. doi: 10.2147/CEOR.S109951. eCollection 2016. Clinicoecon Outcomes Res. 2016. PMID: 27418846 Free PMC article.
-
[Analysis of sugammadex for antagonistic neuromuscular block in patients with radical resection of lung cancer under thoracoscope].Zhonghua Yi Xue Za Zhi. 2020 Jan 21;100(3):213-219. doi: 10.3760/cma.j.issn.0376-2491.2020.03.011. Zhonghua Yi Xue Za Zhi. 2020. PMID: 32008289 Clinical Trial. Chinese.
-
Respiratory events with sugammadex vs. neostigmine following laparoscopic sleeve gastrectomy: a prospective pilot study assessing neuromuscular reversal strategies.Rom J Anaesth Intensive Care. 2017 Oct;24(2):111-114. doi: 10.21454/rjaic.7518.242.evr. Rom J Anaesth Intensive Care. 2017. PMID: 29090263 Free PMC article.
-
The cyclodextrin sugammadex and anaphylaxis to rocuronium: is rocuronium still potentially allergenic in the inclusion complex form?Mini Rev Med Chem. 2012 Jul;12(8):701-12. doi: 10.2174/138955712801264828. Mini Rev Med Chem. 2012. PMID: 22512555 Review.
-
Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials.J Clin Anesth. 2016 Dec;35:1-12. doi: 10.1016/j.jclinane.2016.06.018. Epub 2016 Aug 4. J Clin Anesth. 2016. PMID: 27871504 Review.
References
-
- Tobias JD. Current evidence for the use of sugammadex in children. Paediatr Anaesth. 2017;27:118–25. - PubMed
-
- Akha AS, Rosa J, 3rd, Jahr JS, Li A, Kiai K. Sugammadex:cyclodextrins development of selective binding agents pharmacology, clinical development and future directions. Anesthesiol Clin. 2010;28:691–708. - PubMed
LinkOut - more resources
Full Text Sources